Yup, so sad to see Msia having more new Covid cases comapred with US with population of 300mil

MFCB provides stable income over the period of the concession for the hydropower and the packaging biz offer some extra growth prospect to the counter.

In short it's a dividend yield counter and don't expect it to grow 100% in share price annually unlike previous years as the hype of the hydropower anticipated earnings had materialized.

Unless, there is new catalyst like building a new hydropower or buying a packaging biz or new biz venture that offers 50% to 100% increase to top line and bottomline annually, nothing will much the share price tremendously.

Those wise investors would have entered the counter between 2014-2016 and now receiving dividend yield of 12%-15% p.a. on top of their capital appreciation.

https://www.theedgemarkets.com/article/semiconductor-players-warn-major-industry-impact-if-ee-ops-not-allowed-operate-under-emco


Previous MCO in 2020 , E&E operated right?

Why now cannot operate?

Any idea or new why EPF paring down stakes from 10% till now.

@telurgoreng , totally agreed.

Many of them here not from the generation of what happens to Enron and Arthur Anderson.

So they have no knowledge of stocks of billion dollar market cap can become zero.

Enhancing a high foundry is not done overnight.

If you want to see it grows in value, 3-5 yrs time and depends on the amount of money injected from right partners.

Look at big foundries eg:TSMC & Samsung, their capex per yr is at least USD10 bil per annum.

Yeah, Silterra is old tech with 20nm to 110nm, still need at least 10%(USD 1bil p.a) to stay relevant.

That's why Khazanah bow out.

@glovefinish ,basic principle Law of supply and demand.

Just like Enron guys, after years of legal action only admit mistake.

Here' the court transcript:

"Sir, you have a long list of people to blame for Enron's collapse, and it gets longer and longer as you testify. And your list of people to blame and events to blame did not include yourself, did it, sir?"

https://www.theguardian.com/business/2006/may/03/corporatefraud.enron

Finally, we know that Webank from Tencent is not collaborating with Gpacket.

Still have many ppl putting their head into SD while SD is on chopping board.

Individuals with better visibility like directors already left or sold their shares eg: DATO' AWANG DAUD BIN AWANG PUTERA, HASMAN YUSRI BIN YUSOFF,ROZILAWATI BINTI HAJI BASIR,SHARIFAH IRINA BINTI SYED AHMAD RADZI, MASLEENA BINTI ZAID and TENGKU HASMUDDIN TENGKU OTHMAN.

Compare DNEX with Globalfoundries.
Any hope?

https://www.forbes.com/sites/tiriasresearch/2019/09/17/globalfoundries-change-in-strategy-pays-off/?sh=5129f36d1d37

@willc48

Please be respectful of everyone here.

Only the illiterates or unlearned, will make such comments.

Company burning cash as MCO continues. Low footfall and early closure time not helping.


Even during non-MCO period between february-april don't provide much to the bottom line.

Likely private placement or rights issue by next quarter if they want to target 30-40 CU stores by year end.

Harta moving towards pre-pandemic price level of below RM6.

Demand for gloves normalizing, a good sign that smaller new players will eventually struggle and go out of biz.

I think Serba made the wrong move of firing KPMG.

Using KPMG as existing auditor will only focus on items identified earlier.

Putting EY into the spotlight, is like giving additional pair of eyes to look from different angle and more dirt or skeletons maybe identified in the process.

Hopefully, MCMC will give green light.

The key approval for this is the Competition Act 2010.

Buy back when the dust settles for glove sector.

Though on normal days, glove counters are boring with little dividend and low volume.

It's only exciting this round as the aspect of ASP surge 350%.

Else with pre-pandemic ASP, nitrile glove are sold USD17-USD22 (per 1000) depending on product types, hardly catch anyone's eyes.

ASP at that range only gives profit margin from 9%-15%.

@pjseow

Most glove makers had huge dependency on US market, abt 50% revenue derived from there. Looking at US recovery from Covid, demand is already reducing monthly, couple with lower ASP month-on-month, it's not helping as well.

Though you can still keep Supermax in the long term, >5 yrs, fundamentally sound.

PBB probably got in during the IPO price of ard 40 cent(adj for bonus issue)

Customers benefit the most out of these merger by enjoying telco towers capacity and coverage from 2 companies.

Besides that, due to synergy, mobile data and call plans will be cheaper by 10%-15%.

Thus, there may be will substantial migration of customers from Maxis to Celcom-Digi, due to better coverage, cheaper plans and efficient operations.

Normally, in merger expect some layoff, but in view this merger does not involve that, existing staff will be more motivated and to prove themself better the incumbent staff coming in from another telco.

https://www.theedgemarkets.com/article/after-10-years-trial-transmile-accounting-scandal-case-nearing-end

If Foxconn takes up the private placement, then it would benefit as major shareholder's from the profitability of Silterra.

As its current 5%, shareholding may not have much impact and is possibly only giving advisory to Silterra.

@kinuxian, the medical centre revenue is too small at this moment for listing.
Based on latest quarter result, only rm170mil or annualised it to RM680mil est.
You can compare with IHH and even small ones like KPJ for reference.

I believe,they will wait for the remaining 5 hospitals that will complete in 2024.
It will have better valuation.

Production capacity had grown more than50% to 105 bil by year end, would not expect the share price to dip below pre-pandemic level of RM1.50(adj price).

By then, US CBP would have been lifted, RM2.30-Rm2.50 more likely.

QR should be out next week.

Since it's quarter is from feb-april without MCO, it should do better.

Else I think they really need to revaluate their strategy.

Gooshen, hike in 2023.

Still have many months to go.

Make sure you still around to see it.

https://www.silterra.com/about-us/corporate-information#section01

Will these set of people bring Silterra to next level?

@RHIB7,

Now I know some people here do not know how to compute.

What a shame.

Let's show you how to compute:

Q1-USD100
Q2-USD80
Q3-USD64
Q4-USD51.20
Q5-USD40.96
Q6-USD32.77
Q7-USD26.21
Q8-20.97------------This will likely hit when supply flushing in with newbies like Mahsing,Johan,China-like players,etc

Posted by RHBIB7 > Jun 9, 2021 7:42 PM | Report Abuse

Wow, more than my estimate of 10% per quarter.
-------------------
This is the most silly projection
If one quarter falls 20%
5 more quarter selling price=RM0??

Nitrile glove ASP fell 20% for the Q3.

Wow, more than my estimate of 10% per quarter.




https://www.theedgemarkets.com/article/top-glove-sees-glove-prices-continue-falling-coming-months

As expected from Topglove results, ASP price declining reflecting in latest result.

Last quarter is peak quarter.

Maybe be another Transmile, Wirecard, Hin Leong, Enron,etc

ionlywanttoearn, this theme can only be used for healthy companies.

No one knows exactly how deep is the audit issue unless you are the company management.

Assuming the audit results from independent review that the orderbook is fake, even at RM0.10, no one is willing to buy.

There's more than 100 companies out there to buy.

Stay safe.

wallstreetrookie, there's a few like Xpeng, NIO, Vinfast.

However, not easy to be part of their supply chain, Greatech must prove themself.

Back then, Hibiscus has this mission statement. I guess it didn't achieve.

Mission (2017 – 2021)
We have disclosed our business objectives for the period 2017 to 2021. These business goals are
repeated herewith:
• 100 mmbbls net proven and probable oil reserves/entitlement in existing core asset areas;
and,
• 20,000 bbls/day net production.

Over the last 4 years, the company had been on a acquiring spree for new assets, many private placements but the share price consistently around rm1 and below.

Yinson management reply?
Normally, they will address it in proper channel like Bursa Malaysia or press conference.

Thanks icst1975


I missed the AGM earlier.

Going for another limit down today at closing?

https://finance.yahoo.com/news/broadcom-avgo-q2-earnings-revenues-133601727.html

What a shame for SD.
A darling among O&G.
But could feel something amiss since IPO where it kept producing impressive results and orderbook growing despite pandemic.

No much catalyst for upside in price or dividend as Attarat capacity of 554MW will offset the decommission of Paka 585MW.

With Paka plant operation ending 30/6/2021, expect reduction quarterly in revenue of 10% and 35% PAT in Q4 2021 result.

Attarat issue will probably be resolved by year end.

Likely new contributions from Attarat may come after Q3 2022

Wrong channel?
Should have posted to Twitter, Facebook or NST/STar newspaper

@pjseow

https://disclosure.bursamalaysia.com/FileAccess/apbursaweb/download?id=213850&name=EA_FR_ATTACHMENTS

https://focusmalaysia.my/featured/glove-average-selling-price-is-not-expected-to-fall-off-a-cliff/

https://seekingalpha.com/article/4428004-top-glove-glove-price-decline-and-dual-listing-draw-attention

https://www.theedgemarkets.com/article/glove-stocks-red-amid-concerns-over-mounting-pressure-selling-prices-and-overcapacity

stockwin, the computation is not correct even with assumptions.

Currently, ASP are declining approximately 10% every quarter.

And ASP is a key component in revenue.

If CBP blacklist Supermax, ASP should reduce further as American market has 5% premium in ASP.

Actually, KPOWER and SCIB also have same modus operandi, 2 PP in the last 12 months

Mabel, I believe Karim may not be aware of the issue.

The focus is on his subordinates whether clean or dirty.

Time will tell.

I don't think anyone cares about this.
Out of 1,000 ppl here, at least 70% are punters/day traders/short term(<3mths) trader which can be justified by the volume generated.

Anyone looking into Pfizer, J&J AZ,etc?

Pinky, revenues and profit are number that can be manipulated.

You can read Enron Scandal as a case study.